Janice Brown

Publications

• Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. Johnston L, Florek M, Armstrong R, McCune JS, Arai S, Brown J, Laport G, Lowsky R, Miklos D, Shizuru J, Sheehan K, Lavori P, Negrin R. Bone Marrow Transplant. 2012; 47 (4): 581-8
• Combined effects of interleukin-7 and stem cell factor administration on lymphopoiesis after murine bone marrow transplantation. Chung B, Min D, Joo LW, Krampf MR, Huang J, Yang Y, Shashidhar S, Brown J, Dudl EP, Weinberg KI. Biol Blood Marrow Transplant. 2011; 17 (1): 48-60
• Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen. Schaenman JM, Shashidhar S, Rhee C, Wong J, Navato S, Wong RM, Ho DY, Arai S, Johnston L, Brown JM. Biol Blood Marrow Transplant. 2011; 17 (5): 693-702
• Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. Naik S, Wong R, Arai S, Brown J, Laport G, Lowsky R, Miklos D, Shizuru J, Blume K, Negrin R, Johnston L. Bone Marrow Transplant. 2011; 46 (2): 192-9
• Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Kim JH, Schaenman JM, Ho DY, Brown JM. Biol Blood Marrow Transplant. 2011; 17 (2): 259-64
• A 39-year-old woman with lupus, myositis, and a recalcitrant vasculopathy. Sokolove J, Copland A, Shirvani S, Brown J, Posley K, Chung L. Arthritis Care Res (Hoboken). 2010; 62 (9): 1351-6
• Utility of influenza vaccination for oncology patients. Pollyea DA, Brown JM, Horning SJ. J Clin Oncol. 2010; 28 (14): 2481-90
• Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. Vana ML, Formankova D, Cha S, Sharma A, Potena L, Brown JM, Mocarski ES. Clin Infect Dis. 2008; 47 (4): 535-9
• Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. Wloch MK, Smith LR, Boutsaboualoy S, Reyes L, Han C, Kehler J, Smith HD, Selk L, Nakamura R, Brown JM, Marbury T, Wald A, Rolland A, Kaslow D, Evans T, Boeckh M. J Infect Dis. 2008; 197 (12): 1634-42
• The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Nguyen VH, Shashidhar S, Chang DS, Ho L, Kambham N, Bachmann M, Brown JM, Negrin RS. Blood. 2008; 111 (2): 945-53
• Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES. Blood. 2006; 107 (1): 30-8
• Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature. Cha S, Johnston L, Natkunam Y, Brown J. Transpl Infect Dis. 2005 Sep-Dec; 7 (3-4): 158-61
• Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. Brown JM, Curr Opin Infect Dis. 2005; 18 (4): 352-8
• Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. Arber C, Bitmansour A, Shashidhar S, Wang S, Tseng B, Brown JM. J Infect Dis. 2005; 192 (9): 1666-71
• Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ. Biol Blood Marrow Transplant. 2005; 11 (1): 47-55
• Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. Dvorak CC, Steinbach WJ, Brown JM, Agarwal R. Bone Marrow Transplant. 2005; 36 (7): 621-9
• Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. BitMansour A, Cao TM, Chao S, Shashidhar S, Brown JM. Blood. 2005; 105 (9): 3535-7
• Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. García-Ojeda ME, Dejbakhsh-Jones S, Chatterjea-Matthes D, Mukhopadhyay A, BitMansour A, Weissman IL, Brown JM, Strober S. J Immunol. 2005; 175 (7): 4363-73
• The influence of the conditions of hematopoietic cell transplantation on infectious complications. Brown JM, Curr Opin Infect Dis. 2005; 18 (4): 346-51
• Fungal infections in bone marrow transplant patients. Brown JM, Curr Opin Infect Dis. 2004; 17 (4): 347-52
• Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Arber C, BitMansour A, Sparer TE, Higgins JP, Mocarski ES, Weissman IL, Shizuru JA, Brown JM. Blood. 2003; 102 (2): 421-8
• Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. BitMansour A, Burns SM, Traver D, Akashi K, Contag CH, Weissman IL, Brown JM. Blood. 2002; 100 (13): 4660-7
• Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation. BitMansour A, Brown JM. J Infect Dis. 2002; 186 (1): 134-7
• Immunity to infections following hematopoietic cell transplantation. Brown JM, Weissman IL, Shizuru JA. Curr Opin Immunol. 2001; 13 (4): 451-7
• Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Mocarski ES, Prichard MN, Tan CS, Brown JM. Virology. 1997; 239 (1): 169-75
• Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. Brown JM, Kaneshima H, Mocarski ES. J Infect Dis. 1995; 171 (6): 1599-603
• Selectable insertion and deletion mutagenesis of the human cytomegalovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. Greaves RF, Brown JM, Vieira J, Mocarski ES. J Gen Virol. 1995: 76 ( Pt 9) 2151-60